![](/images/graphics-bg.png)
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
Joint Authors
Sarzi-Puttini, Piercarlo
Atzeni, Fabiola
Manfredi, Mariangela
Benucci, Maurizio
Saviola, Gianantonio
Source
International Journal of Rheumatology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-11-22
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
The cost effectiveness of treatments that have changed the “natural history” of a chronic progressive disease needs to be evaluated over the long term.
Disease-modifying antirheumatic drugs (DMARDs) are the standard treatment of rheumatoid arthritis (RA) and should be started as early as possible.
A number of studies have shown that they are effective in improving disease activity and function, and in joint damage.
Our review was focused on revision and critical evaluation of the studies including the literature on cost effectiveness of DMARDs (cyclosporine A, sulphasalazine, leflunomide, and methotrexate).
The European League Against Rheumatism (EULAR) recommendations showed that traditional DMARDs are cost effective at the time of disease onset.
They are less expensive than biological DMARDs and can be useful in controlling disease activity in early RA.
American Psychological Association (APA)
Benucci, Maurizio& Saviola, Gianantonio& Manfredi, Mariangela& Sarzi-Puttini, Piercarlo& Atzeni, Fabiola. 2011. Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature. International Journal of Rheumatology،Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-502809
Modern Language Association (MLA)
Benucci, Maurizio…[et al.]. Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature. International Journal of Rheumatology No. 2011 (2011), pp.1-6.
https://search.emarefa.net/detail/BIM-502809
American Medical Association (AMA)
Benucci, Maurizio& Saviola, Gianantonio& Manfredi, Mariangela& Sarzi-Puttini, Piercarlo& Atzeni, Fabiola. Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature. International Journal of Rheumatology. 2011. Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-502809
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-502809